Related Experiment Video
Updated: Sep 18, 2025

In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers
Published on: August 1, 2014
ICAM-1 autoantibodies detected in healthy individuals and cross-react with functional epitopes
Marc L Herman1,2, Eric S Geanes1, Rebecca McLennan1
1Genomic Medicine Center, Children's Mercy Research Institute, Kansas City, MO, United States.
Insights
Autoantibodies against Intracellular Adhesion Molecule 1 (ICAM-1) increase with age and decrease in inflammatory conditions. These autoantibodies target functional sites and may arise from molecular mimicry, impacting immune regulation.
Area of Science:
- Immunology
- Molecular Biology
Background:
- Intracellular Adhesion Molecule 1 (ICAM-1) is a cell surface glycoprotein crucial for cell interactions and immune responses.
- Elevated ICAM-1 expression is observed in infections and inflammatory diseases, with anti-ICAM-1 therapies showing clinical success.
- Naturally occurring autoantibodies play roles in immunoregulation, influencing health and disease states.
Purpose of the Study:
- To investigate the presence and levels of ICAM-1 autoantibodies across different age groups and disease states.
- To identify specific epitopes targeted by ICAM-1 autoantibodies and their functional relevance.
- To characterize the IgG subclass distribution of ICAM-1 autoantibodies and explore potential triggers for their generation.
Main Methods:
- Quantification of ICAM-1 autoantibody levels in various age groups and disease cohorts.
- Peptide microarray analysis to map ICAM-1 autoantibody epitopes.
- Determination of IgG subclass (e.g., IgG2) enrichment for anti-ICAM-1 antibodies.
Main Results:
- ICAM-1 autoantibody levels demonstrated an age-dependent increase.
- Lower ICAM-1 autoantibody levels were observed in individuals with inflammatory conditions.
- Identified epitopes targeted by autoantibodies overlapped with critical ICAM-1 functional binding sites.
- ICAM-1 autoantibodies were significantly enriched for the IgG2 subclass.
Conclusions:
- ICAM-1 autoantibodies exhibit a dynamic role in immune regulation, influenced by age and inflammatory status.
- The targeting of functional ICAM-1 sites by autoantibodies suggests potential modulation of ICAM-1 activity.
- Enrichment of IgG2 subclass points towards potential triggers like molecular mimicry of bacterial antigens or immune dysregulation.
- Further understanding of ICAM-1 autoantibodies could offer new therapeutic strategies for inflammatory and autoimmune diseases.
Abstract:
Intracellular adhesion molecule 1 (ICAM-1) is a cell surface glycoprotein that regulates cell-cell interactions, signaling, and immune processes. ICAM-1 expression has been shown to be elevated in many types of infections and inflammatory diseases. Strategies to block ICAM-1 function, including monoclonal anti-ICAM-1 antibodies, have been successful in treating the effects of chronic respiratory, autoimmune, and cardiovascular diseases. Naturally occurring autoantibodies targeting cytokines, endothelial cells, and other host receptors have been identified, and have been found to play a role in immunoregulation in health and disease. In this study, we determined the presence and levels of ICAM-1 autoantibodies across different age groups and disease states. We found that ICAM-1 autoantibody levels increased with age and were lower in individuals with various inflammatory states, suggesting a dynamic role in immune regulation. Using peptide microarrays, we identified high-resolution epitopes targeted by ICAM-1 autoantibodies that overlap with critical functional ICAM-1 binding sites. Finally, we determined that ICAM-1 autoantibodies were enriched for the IgG2 subclass that is critical for the response to bacterial antigens and chronic inflammation. This could indicate that molecular mimicry of bacterial antigens or underlying immune dysregulation could trigger the generation of anti-ICAM-1 antibodies. Understanding the functional implications of ICAM-1 autoantibodies could provide new insights into their contribution to immune homeostasis and their potential impact on inflammatory and autoimmune conditions.
More Related Videos
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Related Concept Videos
Cross-reactivity
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...